Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Capital Expenditures: 2019-2023

Historic Capital Expenditures for P3 Health Partners (PIII) over the last 5 years, with FY2023 value amounting to $1.8 million.

  • P3 Health Partners' Capital Expenditures fell 32400.0% to -$212000.0 in Q4 2023 from the same period last year, while for Jun 2024 it was -$212000.0, marking a year-over-year decrease of 11026.14%. This contributed to the annual value of $1.8 million for FY2023, which is 1818.18% down from last year.
  • As of FY2023, P3 Health Partners' Capital Expenditures stood at $1.8 million, which was down 1818.18% from $2.2 million recorded in FY2022.
  • In the past 5 years, P3 Health Partners' Capital Expenditures ranged from a high of $3.3 million in FY2021 and a low of $1.5 million during FY2019
  • Moreover, its 5-year median value for Capital Expenditures was $2.2 million (2022), whereas its average is $2.3 million.
  • Per our database at Business Quant, P3 Health Partners' Capital Expenditures surged by 10157.72% in 2020 and then plummeted by 1818.18% in 2023.
  • P3 Health Partners' Capital Expenditures (Annual) stood at $1.5 million in 2019, then soared by 101.58% to $2.9 million in 2020, then grew by 12.42% to $3.3 million in 2021, then tumbled by 32.13% to $2.2 million in 2022, then dropped by 18.18% to $1.8 million in 2023.
  • Its Capital Expenditures stands at $1.8 million for FY2023, versus $2.2 million for FY2022 and $3.3 million for FY2021.